Literature DB >> 12618561

Lipoatrophic diabetes and other related syndromes.

Elif Arioglu Oral1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12618561     DOI： 10.1023/a:1021827520301

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  129 in total

1.  Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy.

Authors:  H Cao; R A Hegele
Journal:  Hum Mol Genet       Date:  2000-01-01       Impact factor: 6.150

Review 2.  Indirect calorimetry.

Authors:  E Jéquier; J P Felber
Journal:  Baillieres Clin Endocrinol Metab       Date:  1987-11

3.  Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy.

Authors:  M Raffaele Di Barletta; E Ricci; G Galluzzi; P Tonali; M Mora; L Morandi; A Romorini; T Voit; K H Orstavik; L Merlini; C Trevisan; V Biancalana; I Housmanowa-Petrusewicz; S Bione; R Ricotti; K Schwartz; G Bonne; D Toniolo
Journal:  Am J Hum Genet       Date:  2000-03-16       Impact factor: 11.025

4.  Renal disease in partial lipodystrophy.

Authors:  A J Eisinger; J R Shortland; P J Moorhead
Journal:  Q J Med       Date:  1972-07

Review 5.  Generalized lipodystrophy, congenital and acquired (lipoatrophy).

Authors:  M Seip; O Trygstad
Journal:  Acta Paediatr Suppl       Date:  1996-06

6.  A missense mutation in the exon 8 of lamin A/C gene in a Japanese case of autosomal dominant limb-girdle muscular dystrophy and cardiac conduction block.

Authors:  T Kitaguchi; S Matsubara; M Sato; K Miyamoto; S Hirai; K Schwartz; G Bonne
Journal:  Neuromuscul Disord       Date:  2001-09       Impact factor: 4.296

7.  Direct interaction between emerin and lamin A.

Authors:  L Clements; S Manilal; D R Love; G E Morris
Journal:  Biochem Biophys Res Commun       Date:  2000-01-27       Impact factor: 3.575

8.  Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety).

Authors:  A Garg
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

9.  A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.

Authors:  A Carr; K Samaras; S Burton; M Law; J Freund; D J Chisholm; D A Cooper
Journal:  AIDS       Date:  1998-05-07       Impact factor: 4.177

10.  Autosomal dominant partial lipodystrophy associated with Rieger anomaly, short stature, and insulinopenic diabetes.

Authors:  D Aarskog; L Ose; H Pande; N Eide
Journal:  Am J Med Genet       Date:  1983-05
View more
  3 in total

1.  Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy.

Authors:  Rebecca J Brown; Elif A Oral; Elaine Cochran; David Araújo-Vilar; David B Savage; Alison Long; Gregory Fine; Taylor Salinardi; Phillip Gorden
Journal:  Endocrine       Date:  2018-04-12       Impact factor: 3.633

Review 2.  Monogenic diabetes in children and young adults: Challenges for researcher, clinician and patient.

Authors:  Annabelle S Slingerland
Journal:  Rev Endocr Metab Disord       Date:  2006-09       Impact factor: 6.514

3.  Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy.

Authors:  Elif A Oral; Phillip Gorden; Elaine Cochran; David Araújo-Vilar; David B Savage; Alison Long; Gregory Fine; Taylor Salinardi; Rebecca J Brown
Journal:  Endocrine       Date:  2019-02-25       Impact factor: 3.633
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.